Multi-Modality Therapy | Surviving Mesothelioma

Immunotherapy and Radiation: A Powerful Mesothelioma Combo

New research suggests that, in the battle against malignant pleural mesothelioma, a treatment combining of immunotherapy drugs with radiotherapy may be a powerful new weapon. Researchers at the University of Pennsylvania reached that conclusion after reviewing the few existing studies on this emerging multimodal mesothelioma treatment for an article in Translational Lung Cancer Research.   Current available treatments for pleural mesothelioma, an aggressive lung-related cancer,  include surgical resection, … Continue reading Immunotherapy and Radiation: A Powerful Mesothelioma Combo »

IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma

The targeted radiotherapy technique known as intensity-modulated radiotherapy (IMRT) may offer a safer way to treat pleural mesothelioma tumors with fewer side effects. Researchers at Gazi University in Ankara, Turkey recently compared the outcomes of  twenty-four radiation therapy plannings in patients with malignant pleural mesothelioma and found that IMRT was both less dangerous and more effective. Radiotherapy for Mesothelioma Radiotherapy is often used in pleural … Continue reading IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma »

New Report May Fuel Debate Over Mesothelioma Surgery

A new Swiss report on the two major types of mesothelioma surgery appears to raise as many questions as it answers, adding fuel to the fire in the ongoing debate over surgical technique. While thoracic surgeons around the world remain divided over the best type of surgery for the asbestos cancer,  the report suggests that the two primary curative approaches have similar rates of complications … Continue reading New Report May Fuel Debate Over Mesothelioma Surgery »

VEGF-Inhibitor Looks Promising for Malignant Mesothelioma

There is more encouraging news about the monoclonal antibody bevacizumab (Avastin) and its potential to boost the effectiveness of chemotherapy for people with malignant pleural mesothelioma. A pair of oncology researchers from Texas have just released their summary of the the most recent published studies on bevacizumab. They conclude that, for the right patients, bevacizumab may improve mesothelioma outcomes and extend survival by blocking tumor blood … Continue reading VEGF-Inhibitor Looks Promising for Malignant Mesothelioma »

Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients

Black American Patient

Mesothelioma patients who experience a recurrence of their asbestos cancer after radical surgery may live longer if they undergo additional rounds of chemotherapy. That conclusion comes from a group of Japanese researchers who performed a retrospective review of 59 consecutive pleural mesothelioma patients who had multimodal mesothelioma treatment that included extrapleural pneumonectomy (EPP) surgery. Study subjects had been treated for malignant mesothelioma at Hyogo College … Continue reading Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients »

New Evidence Supports Post-Surgical IMRT for Mesothelioma Treatment

Just a week after New York researchers published their own study on radiation therapy and mesothelioma surgery, a group of doctors from Texas has reached a similar conclusion – that highly-targeted radiotherapy can improve mesothelioma survival. This week’s study was conducted by radiation oncology specialists at Austin Cancer Centers and Baylor Scott and White Health in Temple, Texas. The team performed a retrospective analysis of 18 … Continue reading New Evidence Supports Post-Surgical IMRT for Mesothelioma Treatment »

Tri-Modality Treatment Extends Mesothelioma Survival

radiologist

New research suggests that a combination of lung-sparing surgery, highly targeted radiotherapy, and chemotherapy may bolster survival in people with malignant pleural mesothelioma. Researchers at Memorial Sloan Kettering Cancer Center in New York have just published some promising findings on trimodality mesothelioma treatment with hemithoracic intensity-modulated pleural radiotherapy (IMPRINT). Conventional RT vs IMPRINT The team analyzed the cases of 209 mesothelioma patients who underwent the … Continue reading Tri-Modality Treatment Extends Mesothelioma Survival »

Platelet Count Linked to Peritoneal Mesothelioma Survival After Surgery

Peritoneal mesothelioma patients whose bodies produce too many blood platelets may not be good candidates for the treatment combination known as CRS with HIPEC. Cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC) is a process for removing as much peritoneal mesothelioma from the abdomen as possible and killing any cancer cells left behind with a wash of heated medication. It has become the preferred … Continue reading Platelet Count Linked to Peritoneal Mesothelioma Survival After Surgery »

Mesothelioma Tumor Thickness May Help Predict Treatment Outcomes

New research out of Canada suggests that mesothelioma tumor thickness could be used to help predict mesothelioma survival and select the best treatments.  Doctors at the University of Toronto compared the thickness of pleural mesothelioma tumors in 65 patients who had not yet received any treatment with their eventual outcomes and found a definite correlation. Summarizing their research in The European Respiratory Journal, the team … Continue reading Mesothelioma Tumor Thickness May Help Predict Treatment Outcomes »

Immunotherapy for Pleural Mesothelioma: Does it Work?

Immunotherapy is an important emerging therapeutic strategy for several types of cancer, but the jury is still out on whether it will eventually be a viable approach for malignant pleural mesothelioma. In a newly-published special report on the immune checkpoint inhibitor tremelimumab, researchers at the University of Salford in the UK call the use of such drugs “largely questionable” for pleural mesothelioma treatment. Their concerns, … Continue reading Immunotherapy for Pleural Mesothelioma: Does it Work? »

Get your free copy of
“Surviving Mesothelioma” Today!